Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses.

The research aimed to evaluate the preventive ability of metaphylactic RNA interference on equine herpesvirus type 1 infection in horses, and investigate if there were any differences in viremia among horses infected with a neuropathogenic strain of this virus which led to equine herpesvirus myeloencephalopathy. They found that administrating RNA interference did not appear to work as a preventive method and there was no prominent viremia in horses infected with the neuropathic strain that developed myeloencephalopathy.

Metaphylactic RNA Interference Evaluation

• This research examined the use of metaphylactic RNA interference as a prevention measure against equine herpesvirus type 1 (EHV-1) – a virus that can cause myeloencephalopathy in horses. This condition is a significant and devastating neurological disease in horses and any potential prevention or treatment is of great interest to equine health practitioners.
• A total of 13 seronegative horses were part of the study. They were exposed to EHV-1 strain Ab4, a neuropathogenic strain of the virus.
• In order to evaluate the meticulations of RNA interference, small interfering RNAs (siRNAs) were introduced to the horses intranasally 24 hours before and after their infection at 12, 24, 36, and 48 hours respectively. Seven horses got EHV-1 specific siRNAs while a control group of six horses was given an irrelevant siRNA.

Data Collection and Analysis

• Data were gathered through physical and neurological examinations, nasal swab specimens, and blood samples for virus isolation and quantitative PCR assay.
• The collected data were then amalgamated with preceding relevant data from a study of 14 horses for a more robust analysis.

Results of the Study

• The researchers observed no remarkable difference in clinical variables, viremia, or detection of EHV-1 in nasal swab specimens between the horses treated with the EHV-1 targeted siRNAs and the control group getting the irrelevant siRNA.
• Additionally, they found no significant differences in viremia between horses that developed equine herpesvirus myeloencephalopathy and those that did not.

Study Conclusions

• The research concluded that the metaphylactic RNA interference strategy using siRNAs targeted against EHV-1 was not protective against the virus when administered before and after infection according to their experimental design.
• Furthermore, it was highlighted that horses infected with the neuropathogenic EHV-1 strain Ab4 that went on to develop myeloencephalopathy did not exhibit a more pronounced viremia.